TGFB1 and neoplasm: Other strategies that target the immunosuppressive microenvironment, specifically by targeting different steps in TGFβ signaling pathway, also show efficacy in reducing invasiveness, migration, and tumor size in murine models of breast [178, 179], glioma [180], and colon cancer [181].